Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.

Moshe Shashar,Naomi Nacasch,Ayelet Grupper,Sydney Benchetrit,Tamar Halperin,Daniel Erez,Ilan Rozenberg,Pnina Shitrit,Yaron Sela,Ori Wand,Keren Cohen-Hagai

American journal of nephrology（2022）

引用 20|浏览5

暂无评分

摘要

Almost all MHD patients developed a substantial humoral response following the booster dose, which was significantly higher than levels reported for MHD patients following administration of 2 doses alone. Further studies and observations are needed to determine the exact timing and dosing schedule.

查看译文

关键词

COVID-19 vaccine,COVID-19 virus,Hemodialysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要